Answers are grounded in this paper and cite their sources.
In vitro study reveals dynamic mechanical compression exacerbates inflammaging in aged human mesenchymal stromal cell spheroids, suggesting a donor-specific platform for osteoarthritis drug screening.
Mechanical cues play a critical role in musculoskeletal homeostasis and disease pathophysiology, where excessive loading induces tissue damage and promotes inflammation. Aging further exacerbates this process, particularly in age-related diseases, such as osteoarthritis (OA). Although both hyper-mechanical loading and aging are known to contribute to chronic inflammation in OA and other age-related diseases, their combined effects remain poorly modeled in vitro. Here, we developed a dynamic 3D culture platform integrating gelatin hydrogels, human bone marrow-derived mesenchymal stromal cell (MSC) spheroids, and a compressive bioreactor to recapitulate joint-like mechanical environments. Gelatin hydrogel-encapsulated MSC spheroids maintained mechanical stability under repeated loading (10–20 kPa) while preserving cell viability and spreading. Aged MSC spheroids exhibited metabolic reprogramming toward glycolysis, elevated secretion of pro-inflammatory cytokines (IL-6 and IL-8), and increased PIEZO1 expression. Compressive loading further amplified inflammatory signaling and promoted M1-like macrophage polarization, particularly in aged donor-derived MSCs, modeling key features of inflammaging. Dexamethasone suppressed inflammatory cytokine secretion and promoted M2-like macrophage polarization, whereas tocilizumab modulated immune responses without reducing cytokine production. This platform establishes a donor-specific, mechanobiological model of inflammaging for precision therapeutic screening in osteoarthritis and related diseases.
No takes yet. Share an insight, caveat, or question.
Thi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: